SlideShare a Scribd company logo
Pharmaceutical Care
Introduction
• The term Pharmaceutical Care was first used by Mikeal et. al. in 1975.
• Information and advice is given to encourage safe and effective use of
medication.
• The principles of pharmaceutical Care are embedded in concept of good
pharmacy practice.
2
Introduction
Definition:
• “Pharmaceutical care is the care of a patient by pharmacist, which is required to assure
safe rational drug use.”
Or
• Pharmaceutical care is the responsible provision of drug therapy for the purpose of
achieving definite outcomes that improve a patient's quality of life.
• These outcomes are
– (1) Cure of a disease
– (2) Elimination or reduction of a patient's symptoms.
– (3) Arresting or slowing of a disease process……..
– (4) Preventing a disease or symptomatology. 3
Introduction
• The community pharmacist are engaging in pharmaceutical care activities as:
1. Patient education programs
2. Immunization
3. Health screening
4. Nutrition services
5. AIDS specialty services.
4
The scope of pharmaceutical care
• The three important key phrases are:
1. The responsible provision of drug therapy
2. Definite (Patient) Outcomes:
3. Quality of life:
5
Introduction
• Pharmaceutical care involves the process through which a pharmacist cooperates with
a patient and other professionals in designing, implementing, and monitoring a
therapeutic plan that will produce specific therapeutic outcomes for the patient.
• This in turn involves three major functions:
(1) identifying potential and actual drug related problems,
(2) resolving actual drug-related problems, and
(3) preventing potential drug-related problems.
6
• Pharmaceutical care is a necessary element of health care, and should be integrated with
other elements.
• Pharmaceutical care is, however, provided for the direct benefit of the patient, and the
pharmacist is responsible directly to the patient for the quality of that care.
• The fundamental relationship in pharmaceutical care is a mutually beneficial exchange in
which the patient grants authority to the provider and the provider gives competence and
commitment (accepts responsibility) to the patient.
• The fundamental goals, processes, and relationships of pharmaceutical care exist
regardless of practice setting.
7
Introduction
Principles of Practice for Pharmaceutical Care
• Pharmaceutical Care is a patient-centered, outcomes oriented pharmacy practice that
requires the pharmacist to work in concert with the patient and the patient's other
healthcare providers to promote health, to prevent disease, and to assess, monitor,
initiate, and modify medication use to assure that drug therapy regimens are safe and
effective.
• The goal of Pharmaceutical Care is to optimize the patient's health-related quality of
life, and achieve positive clinical outcomes, within realistic economic expenditures.
8
How to achieve this goal?
A. A professional relationship must be established and maintained.
B. Patient-specific medical information must be collected, organized, recorded, and
maintained.
C. Patient-specific medical information must be evaluated and a drug therapy plan
developed mutually with the patient.
D. The pharmacist assures that the patient has all supplies, information and knowledge
necessary to carry out the drug therapy plan.
E. The pharmacist reviews, monitors, and modifies the therapeutic plan as necessary and
appropriate, in concert with the patient and healthcare team.
9
Develop Professional Relationship?
A. A professional relationship must be established and maintained.
• Interaction between the pharmacist and the patient must occur to assure that a relationship
based upon caring, trust, open communication, cooperation, and mutual decision making is
established and maintained.
• In this relationship, the pharmacist holds the patient's welfare paramount, maintains an
appropriate attitude of caring for the patient's welfare, and uses all his/her professional
knowledge and skills on the patient's behalf.
• In exchange, the patient agrees to supply personal information and preferences, and
participate in the therapeutic plan.
• The pharmacist develops mechanisms to assure the patient has access to pharmaceutical
care at all times. 10
Collect patient specific medical information?
B. Patient-specific medical information must be collected, organized, recorded, and
maintained.
• Pharmacists must collect and/or generate subjective and objective information regarding the patient's general
health and activity status, past medical history, medication history, social history, diet and exercise history,
history of present illness, and economic situation (financial and insured status).
• Sources of information may include, but are not limited to, the patient, medical charts and reports, pharmacist-
conducted health/physical assessment, the patient's family or caregiver, insurer, and other healthcare providers
including physicians, nurses, mid-level practitioners and other pharmacists.
• Since this information will form the basis for decisions regarding the development and subsequent
modification of the drug therapy plan, it must be timely, accurate, and complete, and it must be organized and
recorded to assure that it is readily retrievable and updated as necessary and appropriate.
• Patient information must be maintained in a confidential manner. 11
Evaluate patient specific medical information?
C. Patient-specific medical information must be evaluated and a drug therapy plan
developed mutually with the patient.
• Based upon a thorough understanding of the patient and his/her condition or disease and its treatment,
the pharmacist must, with the patient and with the patient's other healthcare providers as necessary,
develop an outcomes-oriented drug therapy plan.
• The plan may have various components which address each of the patient's diseases or conditions.
• In designing the plan, the pharmacist must carefully consider the psycho-social aspects of the disease
as well as the potential relationship between the cost and/or complexity of therapy and patient
adherence.
• As one of the patient's advocates, the pharmacist assures the coordination of drug therapy with the
patient's other healthcare providers and the patient. 12
• In addition, the patient must be appraised of
(1) various pros and cons (i.e., cost, side effects, different monitoring aspects, etc.) of the
options relative to drug therapy and
(2) instances where one option may be more beneficial based on the pharmacist's
professional judgment.
• The essential elements of the plan, including the patient's responsibilities, must be
carefully and completely explained to the patient.
• Information should be provided to the patient at a level the patient will understand.
• The drug therapy plan must be documented in the patient's pharmacy record and
communicated to the patient's other healthcare providers as necessary.
13
Pharmacist assurance?
D. The pharmacist assures that the patient has all supplies, information and knowledge
necessary to carry out the drug therapy plan.
• The pharmacist providing Pharmaceutical Care must assume ultimate responsibility for
assuring that his/her patient has been able to obtain, and is appropriately using, any drugs
and related products or equipment called for in the drug therapy plan. The pharmacist must
also assure that the patient has a thorough understanding of the disease and the
therapy/medications prescribed in the plan.
14
Pharmacist Review?
E. The pharmacist reviews, monitors, and modifies the therapeutic plan as necessary
and appropriate, in concert with the patient and healthcare team.
• The pharmacist is responsible for monitoring the patient's progress in achieving the
specific outcomes according to strategy developed in the drug therapy plan.
• The pharmacist coordinates changes in the plan with the patient and the patient's other
healthcare providers as necessary and appropriate in order to maintain or enhance the
safety and/or effectiveness of drug therapy and to help minimize overall healthcare costs.
15
• Patient progress is accurately documented in the pharmacy record and communicated
to the patient and to the patient's other healthcare providers as appropriate.
• The pharmacist shares information with other healthcare providers as the setting for
care changes thus helping assure continuity of care as the patient moves between the
community setting, the institutional setting, and the long-term care setting.
16
FUNCTION
17
Practice Principles
• Pharmaceutical care is however provided for the direct benefit of the patient, and the
pharmacist is responsible directly to the patient for the quality of that care.
• The fundamental relationship in pharmaceutical care is a mutually beneficial exchange
in which the patients grants (entrust) the authority to the provider i.e. Pharmacist; and
the provider(Pharmacist) gives competence and commitment (responsibility) to the
patients.
• Before a pharmacist accept this responsibility to provide pharmaceutical care He/She
must pass through the following criteria
• 1) Must posses knowledge and skills in pharmaceutical care such as clinical
pharmacology…
18
• 2) Must be able to develop relationships with the patients and other health acre professionals
needed to provide pharmaceutical care.
• 3) Must be available in society/community for patients in time
• 4) Should have commitment to quality improvement and assessment procedure.
• 5) Must be able to handle the prescription and medication
In addition to the above qualities of a pharmacist, the following institutional setup has to be in
place:
a) System of data collection, Documentation, and Transfer of information
b) Reference, resources and equipment.
c) Efficient workflow processes
Once the above parameters are in proper place, the pharmacist Who is the central figure for
pharmaceutical care. And then a pharmacist has the following function to perform
19
Functions
1. Collection of patient data
2. Identification of problems
3. Establishing outcome goals through a good therapeutic plan
4. Evaluating treatment alternatives, by monitoring and modifying therapeutic plan
5. Individualizing drug regimens
6. Monitoring outcomes.
20
Functions / Practice Principles
1. Data Collection
2. Information Evaluation
3. Formulating a Plan
4. Implementing the Plan
5. Monitoring and Modifying the Plan/Assuring Positive Outcomes
21
Practice Principles
1. Data Collection
• 1.1 The pharmacist conducts an initial interview with the patient for the purposes of
establishing a professional working relationship and initiating the patient's pharmacy
record.
• In some situations (e.g. pediatrics, geriatrics, critical care, language barriers) the
opportunity to develop a professional relationship with and collect information directly
from the patient may not exist.
• Under these circumstances, the pharmacist should work directly with the patient's parent,
guardian, and/or principal caregiver.
22
• 1.2 The interview is organized, professional, and meets the patient's need for
confidentiality and privacy.
• Adequate time is devoted to assure that questions and answers can be fully developed
without either party feeling uncomfortable or hurried.
• The interview is used to systematically collect patient-specific subjective information and
to initiate a pharmacy record which includes information and data regarding the patient's
general health and activity status, past medical history, medication history, social history
(including economic situation), family history, and history of present illness.
• The record should also include information regarding the patient's thoughts or feelings and
perceptions of his/her condition or disease.
23
• 1.3 The pharmacist uses health/physical assessment techniques (blood-pressure monitoring, etc.)
appropriately and as necessary to acquire necessary patient-specific objective information.
• 1.4 The pharmacist uses appropriate secondary sources to supplement the information obtained
through the initial patient interview and health/physical assessment.
• Sources may include, but are not limited to, the patient's medical record or medical reports, the
patient's family, and the patient's other healthcare providers.
• 1.5 The pharmacist creates a pharmacy record for the patient and accurately records the
information collected. The pharmacist assures that the patient's record is appropriately organized,
kept current, and accurately reflects all pharmacist-patient encounters.
• The confidentiality of the information in the record is carefully guarded and appropriate systems
are in place to assure security.
24
Practice Principles
2. Information Evaluation
• 2.1 The pharmacist evaluates the subjective and objective information collected from the patient and other
sources then forms conclusions regarding:
(1) opportunities to improve and/or assure the safety, effectiveness, and/or economy of current or planned drug
therapy;
(2) opportunities to minimize current or potential future drug or health-related problems; and
(3) the timing of any necessary future pharmacist consultation.
• 2.2 The pharmacist records the conclusions of the evaluation in the medical and/or pharmacy record.
• 2.3 The pharmacist discusses the conclusions with the patient, as necessary and appropriate, and assures an
appropriate understanding of the nature of the condition or illness and what might be expected with respect
to its management.
25
Practice Principles
3. Formulating a Plan
• 3.1 The pharmacist, in concert with other healthcare providers, identifies, evaluates and then
chooses the most appropriate action(s) to: (1) improve and/or assure the safety, effectiveness, and/or
cost-effectiveness of current or planned drug therapy; and/or,
(2) minimize current or potential future health-related problems.
• 3.2 The pharmacist formulates plans to effect the desired outcome.
• The plans may include, but are not limited to, work with the patient as well as with other health
providers to develop a patient-specific drug therapy protocol or to modify prescribed drug therapy,
develop and/or implement drug therapy monitoring mechanisms, recommend nutritional or dietary
modifications, add non-prescription medications or non-drug treatments, refer the patient to an
appropriate source of care, or institute an existing drug therapy protocol.
26
• 3.3 For each problem identified, the pharmacist actively considers the patient's needs and
determines the desirable and mutually agreed upon outcome and incorporates these into the
plan.
• The plan may include specific disease state and drug therapy endpoints and monitoring
endpoints.
• 3.4 The pharmacist reviews the plan and desirable outcomes with the patient and with the
patient's other healthcare provider(s) as appropriate.
• 3.5 The pharmacist documents the plan and desirable outcomes in the patient's medical and/or
pharmacy record.
27
Practice Principles
4. Implementing the Plan
• 4.1 The pharmacist and the patient take the steps necessary to implement the plan.
• These steps may include, but are not limited to,
– contacting other health providers to clarify or modify prescriptions,
– initiating drug therapy,
– educating the patient and/or caregiver(s),
– coordinating the acquisition of medications and/or related supplies, which might include
helping the patient overcome financial barriers or lifestyle barriers that might otherwise
interfere with the therapy plan, or
– coordinating appointments with other healthcare providers to whom the patient is being
referred. 28
• 4.2 The pharmacist works with the patient to maximize patient understanding and involvement in
the therapy plan, assures that arrangements for drug therapy monitoring (e.g. laboratory evaluation,
blood pressure monitoring, home blood glucose testing, etc.) are made and understood by the
patient, and that the patient receives and knows how to properly use all necessary medications and
related equipment.
• Explanations are tailored to the patient's level of comprehension and teaching and adherence aids
are employed as indicated.
• 4.3 The pharmacist assures that appropriate mechanisms are in place to ensure that the proper
medications, equipment, and supplies are received by the patient in a timely fashion.
29
• 4.4 The pharmacist documents in the medical and/or pharmacy record the steps taken to
implement the plan including the appropriate baseline monitoring parameters, and any
barriers which will need to be overcome.
• 4.5 The pharmacist communicates the elements of the plan to the patient and/or the patient's
other healthcare provider(s). The pharmacist shares information with other healthcare
providers as the setting for care changes, in order to help maintain continuity of care as the
patient moves between the ambulatory, inpatient or long-term care environment.
30
Practice Principles
5. Monitoring and Modifying the Plan/Assuring Positive Outcomes
• 5.1 The pharmacist regularly reviews subjective and objective monitoring parameters in order to
determine if satisfactory progress is being made toward achieving desired outcomes as outlined in
the drug therapy plan.
• 5.2 The pharmacist and patient determine if the original plan should continue to be followed or if
modifications are needed. If changes are necessary, the pharmacist works with the patient/caregiver
and his/her other healthcare providers to modify and implement the revised plan as described in
"Formulating the Plan" and "Implementing the Plans" above.
• 5.3 The pharmacist reviews ongoing progress in achieving desired outcomes with the patient and
provides a report to the patient's other healthcare providers as appropriate. As progress towards
outcomes is achieved, the pharmacist should provide positive reinforcement.
31
• 5.4 A mechanism is established for follow-up with patients.
• The pharmacist uses appropriate professional judgment in determining the need to notify the
patient's other healthcare providers of the patient's level of adherence with the plan.
• 5.5 The pharmacist updates the patient's medical and/or pharmacy record with information
concerning patient progress, noting the subjective and objective information which has been
considered, his/her assessment of the patient's current progress, the patient's assessment of
his/her current progress, and any modifications that are being made to the plan.
Communications with other healthcare providers should also be noted.
32
SOAP
33
Thank You
34

More Related Content

What's hot

Legality of prescription..pptx
Legality of prescription..pptxLegality of prescription..pptx
Legality of prescription..pptx
Sumit Tiwari
 
Medication adherence
Medication adherenceMedication adherence
Medication adherence
Subhash Yende
 
Drug information resources
Drug  information resourcesDrug  information resources
Drug information resources
Gyanendra Raj Joshi
 
Chapter 7_Health Screening Services in Community Pharmacy.pptx
Chapter 7_Health Screening Services in Community Pharmacy.pptxChapter 7_Health Screening Services in Community Pharmacy.pptx
Chapter 7_Health Screening Services in Community Pharmacy.pptx
VinayGaikwad14
 
Medication Related Problems
Medication Related ProblemsMedication Related Problems
Medication Related Problems
wef
 
Patient medication adherence
Patient medication adherencePatient medication adherence
Patient medication adherence
Rana Pelluri
 
Pharmaceutical care
Pharmaceutical carePharmaceutical care
Pharmaceutical care
Dr. Ramesh Bhandari
 
Medication Adherence
Medication Adherence Medication Adherence
Medication Adherence
sunayanamali
 
pharmacist patient education and counseling
pharmacist patient education and counseling pharmacist patient education and counseling
pharmacist patient education and counseling
Hemat Elgohary
 
Pharmaceutical care concepts - clinical pharmacy
Pharmaceutical care concepts - clinical pharmacy Pharmaceutical care concepts - clinical pharmacy
Pharmaceutical care concepts - clinical pharmacy
ShaistaSumayya
 
use of computers in community pharmacy
use of computers in community pharmacyuse of computers in community pharmacy
use of computers in community pharmacy
Ramesh Ganpisetti
 
Medication adherence
Medication adherenceMedication adherence
Medication adherence
Prejith Philip Chacko
 
General prescribing guidelines for pediatrics, geriatrics and pregnancy
General prescribing guidelines for pediatrics, geriatrics and pregnancyGeneral prescribing guidelines for pediatrics, geriatrics and pregnancy
General prescribing guidelines for pediatrics, geriatrics and pregnancy
Dr. Ankit Gaur
 
Drug Therapy Monitiring
Drug Therapy MonitiringDrug Therapy Monitiring
Drug Therapy Monitiring
maneeshkumar reddy
 
14ab1t0012 dispensing of narcotics and controlled substances
14ab1t0012   dispensing of narcotics and controlled substances14ab1t0012   dispensing of narcotics and controlled substances
14ab1t0012 dispensing of narcotics and controlled substances
Ramesh Ganpisetti
 
Chapter 8_Over The Counter (OTC) Medications.pptx
Chapter 8_Over The Counter (OTC) Medications.pptxChapter 8_Over The Counter (OTC) Medications.pptx
Chapter 8_Over The Counter (OTC) Medications.pptx
VinayGaikwad14
 
Factors affecting medication adherence
Factors affecting medication adherence Factors affecting medication adherence
Factors affecting medication adherence
Ramesh Ganpisetti
 
pharmaceutical care
pharmaceutical carepharmaceutical care
pharmaceutical care
Dr Arathy R Nath
 
Barriers of patient counseling in a community pharmacy and Strategies to over...
Barriers of patient counseling in a community pharmacy and Strategies to over...Barriers of patient counseling in a community pharmacy and Strategies to over...
Barriers of patient counseling in a community pharmacy and Strategies to over...
MerrinJoseph1
 
Medical adherence
Medical adherenceMedical adherence
Medical adherence
Harshita Jain
 

What's hot (20)

Legality of prescription..pptx
Legality of prescription..pptxLegality of prescription..pptx
Legality of prescription..pptx
 
Medication adherence
Medication adherenceMedication adherence
Medication adherence
 
Drug information resources
Drug  information resourcesDrug  information resources
Drug information resources
 
Chapter 7_Health Screening Services in Community Pharmacy.pptx
Chapter 7_Health Screening Services in Community Pharmacy.pptxChapter 7_Health Screening Services in Community Pharmacy.pptx
Chapter 7_Health Screening Services in Community Pharmacy.pptx
 
Medication Related Problems
Medication Related ProblemsMedication Related Problems
Medication Related Problems
 
Patient medication adherence
Patient medication adherencePatient medication adherence
Patient medication adherence
 
Pharmaceutical care
Pharmaceutical carePharmaceutical care
Pharmaceutical care
 
Medication Adherence
Medication Adherence Medication Adherence
Medication Adherence
 
pharmacist patient education and counseling
pharmacist patient education and counseling pharmacist patient education and counseling
pharmacist patient education and counseling
 
Pharmaceutical care concepts - clinical pharmacy
Pharmaceutical care concepts - clinical pharmacy Pharmaceutical care concepts - clinical pharmacy
Pharmaceutical care concepts - clinical pharmacy
 
use of computers in community pharmacy
use of computers in community pharmacyuse of computers in community pharmacy
use of computers in community pharmacy
 
Medication adherence
Medication adherenceMedication adherence
Medication adherence
 
General prescribing guidelines for pediatrics, geriatrics and pregnancy
General prescribing guidelines for pediatrics, geriatrics and pregnancyGeneral prescribing guidelines for pediatrics, geriatrics and pregnancy
General prescribing guidelines for pediatrics, geriatrics and pregnancy
 
Drug Therapy Monitiring
Drug Therapy MonitiringDrug Therapy Monitiring
Drug Therapy Monitiring
 
14ab1t0012 dispensing of narcotics and controlled substances
14ab1t0012   dispensing of narcotics and controlled substances14ab1t0012   dispensing of narcotics and controlled substances
14ab1t0012 dispensing of narcotics and controlled substances
 
Chapter 8_Over The Counter (OTC) Medications.pptx
Chapter 8_Over The Counter (OTC) Medications.pptxChapter 8_Over The Counter (OTC) Medications.pptx
Chapter 8_Over The Counter (OTC) Medications.pptx
 
Factors affecting medication adherence
Factors affecting medication adherence Factors affecting medication adherence
Factors affecting medication adherence
 
pharmaceutical care
pharmaceutical carepharmaceutical care
pharmaceutical care
 
Barriers of patient counseling in a community pharmacy and Strategies to over...
Barriers of patient counseling in a community pharmacy and Strategies to over...Barriers of patient counseling in a community pharmacy and Strategies to over...
Barriers of patient counseling in a community pharmacy and Strategies to over...
 
Medical adherence
Medical adherenceMedical adherence
Medical adherence
 

Similar to Pharmaceutical Care -Definition and Principles (1).ppt

Pharmaceutical Care
Pharmaceutical CarePharmaceutical Care
Pharmaceutical Care
rifae
 
Good pharmacy practices.pptx
Good pharmacy practices.pptxGood pharmacy practices.pptx
Good pharmacy practices.pptx
AjitKumar428826
 
Pharmaceutical care.pptx
Pharmaceutical care.pptxPharmaceutical care.pptx
Pharmaceutical care.pptx
SunaynaChoudhary
 
Clinical Pharmacy.pptx
Clinical Pharmacy.pptxClinical Pharmacy.pptx
Clinical Pharmacy.pptx
KalloliChatterjee
 
PMY 6110_1-2-Principles - Copy.pdf
PMY 6110_1-2-Principles - Copy.pdfPMY 6110_1-2-Principles - Copy.pdf
PMY 6110_1-2-Principles - Copy.pdf
MuungoLungwani
 
PMY 6110_1-2-Principles of Pharmaceutical Care 1.pdf
PMY 6110_1-2-Principles of Pharmaceutical Care 1.pdfPMY 6110_1-2-Principles of Pharmaceutical Care 1.pdf
PMY 6110_1-2-Principles of Pharmaceutical Care 1.pdf
MuungoLungwani
 
PMY 6110_1-6-Pharmaceutical Care Evaluation.pdf
PMY 6110_1-6-Pharmaceutical Care Evaluation.pdfPMY 6110_1-6-Pharmaceutical Care Evaluation.pdf
PMY 6110_1-6-Pharmaceutical Care Evaluation.pdf
MuungoLungwani
 
Basics of Drug Information.pptx
Basics of Drug Information.pptxBasics of Drug Information.pptx
Basics of Drug Information.pptx
Hhggg8
 
RDP-CP-PP.pdf
RDP-CP-PP.pdfRDP-CP-PP.pdf
RDP-CP-PP.pdf
rishi2789
 
2. Minimum Standard for Hospital Pharmacy_ASHP_2022-2023.pptx
2. Minimum Standard for Hospital Pharmacy_ASHP_2022-2023.pptx2. Minimum Standard for Hospital Pharmacy_ASHP_2022-2023.pptx
2. Minimum Standard for Hospital Pharmacy_ASHP_2022-2023.pptx
ssuserca7d2c
 
Clinical pharmacist in TB & Renal Ward
Clinical pharmacist in TB & Renal WardClinical pharmacist in TB & Renal Ward
Clinical pharmacist in TB & Renal Ward
dhanvishah18
 
Hospital pharmacy service
Hospital pharmacy serviceHospital pharmacy service
Hospital pharmacy service
Muhammad Maroof Ahmad
 
In patient care
In patient careIn patient care
In patient care
Naveed Sarwar
 
PMY 6110_1-4-Pharmaceutical Care Plan.pdf
PMY 6110_1-4-Pharmaceutical Care Plan.pdfPMY 6110_1-4-Pharmaceutical Care Plan.pdf
PMY 6110_1-4-Pharmaceutical Care Plan.pdf
MuungoLungwani
 
Education and training program in the hospital.pptx
Education and training program in the hospital.pptxEducation and training program in the hospital.pptx
Education and training program in the hospital.pptx
Sangam Kanthale
 
Modern dispensing aspects
Modern dispensing aspectsModern dispensing aspects
Modern dispensing aspects
Aimen Salman
 
Clinical pharmacy.pptx
Clinical pharmacy.pptxClinical pharmacy.pptx
Clinical pharmacy.pptx
Alaa Fadhel Hassan Alwazni
 
Pharmaceutical care
Pharmaceutical carePharmaceutical care
Pharmaceutical care
Brahmani baachu
 
Patient_Care_Process_Template_Presentation-Final.pptx
Patient_Care_Process_Template_Presentation-Final.pptxPatient_Care_Process_Template_Presentation-Final.pptx
Patient_Care_Process_Template_Presentation-Final.pptx
DrVivekChauhan1
 
medication adherence.pdf
medication adherence.pdfmedication adherence.pdf
medication adherence.pdf
Arbeena Shakir
 

Similar to Pharmaceutical Care -Definition and Principles (1).ppt (20)

Pharmaceutical Care
Pharmaceutical CarePharmaceutical Care
Pharmaceutical Care
 
Good pharmacy practices.pptx
Good pharmacy practices.pptxGood pharmacy practices.pptx
Good pharmacy practices.pptx
 
Pharmaceutical care.pptx
Pharmaceutical care.pptxPharmaceutical care.pptx
Pharmaceutical care.pptx
 
Clinical Pharmacy.pptx
Clinical Pharmacy.pptxClinical Pharmacy.pptx
Clinical Pharmacy.pptx
 
PMY 6110_1-2-Principles - Copy.pdf
PMY 6110_1-2-Principles - Copy.pdfPMY 6110_1-2-Principles - Copy.pdf
PMY 6110_1-2-Principles - Copy.pdf
 
PMY 6110_1-2-Principles of Pharmaceutical Care 1.pdf
PMY 6110_1-2-Principles of Pharmaceutical Care 1.pdfPMY 6110_1-2-Principles of Pharmaceutical Care 1.pdf
PMY 6110_1-2-Principles of Pharmaceutical Care 1.pdf
 
PMY 6110_1-6-Pharmaceutical Care Evaluation.pdf
PMY 6110_1-6-Pharmaceutical Care Evaluation.pdfPMY 6110_1-6-Pharmaceutical Care Evaluation.pdf
PMY 6110_1-6-Pharmaceutical Care Evaluation.pdf
 
Basics of Drug Information.pptx
Basics of Drug Information.pptxBasics of Drug Information.pptx
Basics of Drug Information.pptx
 
RDP-CP-PP.pdf
RDP-CP-PP.pdfRDP-CP-PP.pdf
RDP-CP-PP.pdf
 
2. Minimum Standard for Hospital Pharmacy_ASHP_2022-2023.pptx
2. Minimum Standard for Hospital Pharmacy_ASHP_2022-2023.pptx2. Minimum Standard for Hospital Pharmacy_ASHP_2022-2023.pptx
2. Minimum Standard for Hospital Pharmacy_ASHP_2022-2023.pptx
 
Clinical pharmacist in TB & Renal Ward
Clinical pharmacist in TB & Renal WardClinical pharmacist in TB & Renal Ward
Clinical pharmacist in TB & Renal Ward
 
Hospital pharmacy service
Hospital pharmacy serviceHospital pharmacy service
Hospital pharmacy service
 
In patient care
In patient careIn patient care
In patient care
 
PMY 6110_1-4-Pharmaceutical Care Plan.pdf
PMY 6110_1-4-Pharmaceutical Care Plan.pdfPMY 6110_1-4-Pharmaceutical Care Plan.pdf
PMY 6110_1-4-Pharmaceutical Care Plan.pdf
 
Education and training program in the hospital.pptx
Education and training program in the hospital.pptxEducation and training program in the hospital.pptx
Education and training program in the hospital.pptx
 
Modern dispensing aspects
Modern dispensing aspectsModern dispensing aspects
Modern dispensing aspects
 
Clinical pharmacy.pptx
Clinical pharmacy.pptxClinical pharmacy.pptx
Clinical pharmacy.pptx
 
Pharmaceutical care
Pharmaceutical carePharmaceutical care
Pharmaceutical care
 
Patient_Care_Process_Template_Presentation-Final.pptx
Patient_Care_Process_Template_Presentation-Final.pptxPatient_Care_Process_Template_Presentation-Final.pptx
Patient_Care_Process_Template_Presentation-Final.pptx
 
medication adherence.pdf
medication adherence.pdfmedication adherence.pdf
medication adherence.pdf
 

Recently uploaded

Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.
Vishal kr Thakur
 
U Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdf
U Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdfU Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdf
U Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdf
Jokerwigs arts and craft
 
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdfChampions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
eurohealthleaders
 
The Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdfThe Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdf
Dr Rachana Gujar
 
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
rightmanforbloodline
 
Can Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdfCan Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdf
Dharma Homoeopathy
 
MBC Support Group for Black Women – Insights in Genetic Testing.pdf
MBC Support Group for Black Women – Insights in Genetic Testing.pdfMBC Support Group for Black Women – Insights in Genetic Testing.pdf
MBC Support Group for Black Women – Insights in Genetic Testing.pdf
bkling
 
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Ear Solutions (ESPL)
 
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdfInnovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
eurohealthleaders
 
Pneumothorax and role of Physiotherapy in it.
Pneumothorax and role of Physiotherapy in it.Pneumothorax and role of Physiotherapy in it.
Pneumothorax and role of Physiotherapy in it.
Vishal kr Thakur
 
Professional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine LectureProfessional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine Lecture
DIVYANSHU740006
 
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DR Jag Mohan Prajapati
 
Letter to MREC - application to conduct study
Letter to MREC - application to conduct studyLetter to MREC - application to conduct study
Letter to MREC - application to conduct study
Azreen Aj
 
Top Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima SpaTop Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima Spa
Chandrima Spa Ajman
 
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
Dr Rachana Gujar
 
Top massage center in ajman chandrima Spa
Top massage center in ajman chandrima  SpaTop massage center in ajman chandrima  Spa
Top massage center in ajman chandrima Spa
Chandrima Spa Ajman
 
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)
bkling
 
2024 HIPAA Compliance Training Guide to the Compliance Officers
2024 HIPAA Compliance Training Guide to the Compliance Officers2024 HIPAA Compliance Training Guide to the Compliance Officers
2024 HIPAA Compliance Training Guide to the Compliance Officers
Conference Panel
 
Luxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage CenterLuxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage Center
Chandrima Spa Ajman
 
R3 Stem Cell Therapy: A New Hope for Women with Ovarian Failure
R3 Stem Cell Therapy: A New Hope for Women with Ovarian FailureR3 Stem Cell Therapy: A New Hope for Women with Ovarian Failure
R3 Stem Cell Therapy: A New Hope for Women with Ovarian Failure
R3 Stem Cell
 

Recently uploaded (20)

Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.
 
U Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdf
U Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdfU Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdf
U Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdf
 
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdfChampions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
 
The Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdfThe Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdf
 
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
 
Can Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdfCan Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdf
 
MBC Support Group for Black Women – Insights in Genetic Testing.pdf
MBC Support Group for Black Women – Insights in Genetic Testing.pdfMBC Support Group for Black Women – Insights in Genetic Testing.pdf
MBC Support Group for Black Women – Insights in Genetic Testing.pdf
 
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
 
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdfInnovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
 
Pneumothorax and role of Physiotherapy in it.
Pneumothorax and role of Physiotherapy in it.Pneumothorax and role of Physiotherapy in it.
Pneumothorax and role of Physiotherapy in it.
 
Professional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine LectureProfessional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine Lecture
 
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
 
Letter to MREC - application to conduct study
Letter to MREC - application to conduct studyLetter to MREC - application to conduct study
Letter to MREC - application to conduct study
 
Top Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima SpaTop Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima Spa
 
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
 
Top massage center in ajman chandrima Spa
Top massage center in ajman chandrima  SpaTop massage center in ajman chandrima  Spa
Top massage center in ajman chandrima Spa
 
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)
 
2024 HIPAA Compliance Training Guide to the Compliance Officers
2024 HIPAA Compliance Training Guide to the Compliance Officers2024 HIPAA Compliance Training Guide to the Compliance Officers
2024 HIPAA Compliance Training Guide to the Compliance Officers
 
Luxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage CenterLuxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage Center
 
R3 Stem Cell Therapy: A New Hope for Women with Ovarian Failure
R3 Stem Cell Therapy: A New Hope for Women with Ovarian FailureR3 Stem Cell Therapy: A New Hope for Women with Ovarian Failure
R3 Stem Cell Therapy: A New Hope for Women with Ovarian Failure
 

Pharmaceutical Care -Definition and Principles (1).ppt

  • 2. Introduction • The term Pharmaceutical Care was first used by Mikeal et. al. in 1975. • Information and advice is given to encourage safe and effective use of medication. • The principles of pharmaceutical Care are embedded in concept of good pharmacy practice. 2
  • 3. Introduction Definition: • “Pharmaceutical care is the care of a patient by pharmacist, which is required to assure safe rational drug use.” Or • Pharmaceutical care is the responsible provision of drug therapy for the purpose of achieving definite outcomes that improve a patient's quality of life. • These outcomes are – (1) Cure of a disease – (2) Elimination or reduction of a patient's symptoms. – (3) Arresting or slowing of a disease process…….. – (4) Preventing a disease or symptomatology. 3
  • 4. Introduction • The community pharmacist are engaging in pharmaceutical care activities as: 1. Patient education programs 2. Immunization 3. Health screening 4. Nutrition services 5. AIDS specialty services. 4
  • 5. The scope of pharmaceutical care • The three important key phrases are: 1. The responsible provision of drug therapy 2. Definite (Patient) Outcomes: 3. Quality of life: 5
  • 6. Introduction • Pharmaceutical care involves the process through which a pharmacist cooperates with a patient and other professionals in designing, implementing, and monitoring a therapeutic plan that will produce specific therapeutic outcomes for the patient. • This in turn involves three major functions: (1) identifying potential and actual drug related problems, (2) resolving actual drug-related problems, and (3) preventing potential drug-related problems. 6
  • 7. • Pharmaceutical care is a necessary element of health care, and should be integrated with other elements. • Pharmaceutical care is, however, provided for the direct benefit of the patient, and the pharmacist is responsible directly to the patient for the quality of that care. • The fundamental relationship in pharmaceutical care is a mutually beneficial exchange in which the patient grants authority to the provider and the provider gives competence and commitment (accepts responsibility) to the patient. • The fundamental goals, processes, and relationships of pharmaceutical care exist regardless of practice setting. 7 Introduction
  • 8. Principles of Practice for Pharmaceutical Care • Pharmaceutical Care is a patient-centered, outcomes oriented pharmacy practice that requires the pharmacist to work in concert with the patient and the patient's other healthcare providers to promote health, to prevent disease, and to assess, monitor, initiate, and modify medication use to assure that drug therapy regimens are safe and effective. • The goal of Pharmaceutical Care is to optimize the patient's health-related quality of life, and achieve positive clinical outcomes, within realistic economic expenditures. 8
  • 9. How to achieve this goal? A. A professional relationship must be established and maintained. B. Patient-specific medical information must be collected, organized, recorded, and maintained. C. Patient-specific medical information must be evaluated and a drug therapy plan developed mutually with the patient. D. The pharmacist assures that the patient has all supplies, information and knowledge necessary to carry out the drug therapy plan. E. The pharmacist reviews, monitors, and modifies the therapeutic plan as necessary and appropriate, in concert with the patient and healthcare team. 9
  • 10. Develop Professional Relationship? A. A professional relationship must be established and maintained. • Interaction between the pharmacist and the patient must occur to assure that a relationship based upon caring, trust, open communication, cooperation, and mutual decision making is established and maintained. • In this relationship, the pharmacist holds the patient's welfare paramount, maintains an appropriate attitude of caring for the patient's welfare, and uses all his/her professional knowledge and skills on the patient's behalf. • In exchange, the patient agrees to supply personal information and preferences, and participate in the therapeutic plan. • The pharmacist develops mechanisms to assure the patient has access to pharmaceutical care at all times. 10
  • 11. Collect patient specific medical information? B. Patient-specific medical information must be collected, organized, recorded, and maintained. • Pharmacists must collect and/or generate subjective and objective information regarding the patient's general health and activity status, past medical history, medication history, social history, diet and exercise history, history of present illness, and economic situation (financial and insured status). • Sources of information may include, but are not limited to, the patient, medical charts and reports, pharmacist- conducted health/physical assessment, the patient's family or caregiver, insurer, and other healthcare providers including physicians, nurses, mid-level practitioners and other pharmacists. • Since this information will form the basis for decisions regarding the development and subsequent modification of the drug therapy plan, it must be timely, accurate, and complete, and it must be organized and recorded to assure that it is readily retrievable and updated as necessary and appropriate. • Patient information must be maintained in a confidential manner. 11
  • 12. Evaluate patient specific medical information? C. Patient-specific medical information must be evaluated and a drug therapy plan developed mutually with the patient. • Based upon a thorough understanding of the patient and his/her condition or disease and its treatment, the pharmacist must, with the patient and with the patient's other healthcare providers as necessary, develop an outcomes-oriented drug therapy plan. • The plan may have various components which address each of the patient's diseases or conditions. • In designing the plan, the pharmacist must carefully consider the psycho-social aspects of the disease as well as the potential relationship between the cost and/or complexity of therapy and patient adherence. • As one of the patient's advocates, the pharmacist assures the coordination of drug therapy with the patient's other healthcare providers and the patient. 12
  • 13. • In addition, the patient must be appraised of (1) various pros and cons (i.e., cost, side effects, different monitoring aspects, etc.) of the options relative to drug therapy and (2) instances where one option may be more beneficial based on the pharmacist's professional judgment. • The essential elements of the plan, including the patient's responsibilities, must be carefully and completely explained to the patient. • Information should be provided to the patient at a level the patient will understand. • The drug therapy plan must be documented in the patient's pharmacy record and communicated to the patient's other healthcare providers as necessary. 13
  • 14. Pharmacist assurance? D. The pharmacist assures that the patient has all supplies, information and knowledge necessary to carry out the drug therapy plan. • The pharmacist providing Pharmaceutical Care must assume ultimate responsibility for assuring that his/her patient has been able to obtain, and is appropriately using, any drugs and related products or equipment called for in the drug therapy plan. The pharmacist must also assure that the patient has a thorough understanding of the disease and the therapy/medications prescribed in the plan. 14
  • 15. Pharmacist Review? E. The pharmacist reviews, monitors, and modifies the therapeutic plan as necessary and appropriate, in concert with the patient and healthcare team. • The pharmacist is responsible for monitoring the patient's progress in achieving the specific outcomes according to strategy developed in the drug therapy plan. • The pharmacist coordinates changes in the plan with the patient and the patient's other healthcare providers as necessary and appropriate in order to maintain or enhance the safety and/or effectiveness of drug therapy and to help minimize overall healthcare costs. 15
  • 16. • Patient progress is accurately documented in the pharmacy record and communicated to the patient and to the patient's other healthcare providers as appropriate. • The pharmacist shares information with other healthcare providers as the setting for care changes thus helping assure continuity of care as the patient moves between the community setting, the institutional setting, and the long-term care setting. 16
  • 18. Practice Principles • Pharmaceutical care is however provided for the direct benefit of the patient, and the pharmacist is responsible directly to the patient for the quality of that care. • The fundamental relationship in pharmaceutical care is a mutually beneficial exchange in which the patients grants (entrust) the authority to the provider i.e. Pharmacist; and the provider(Pharmacist) gives competence and commitment (responsibility) to the patients. • Before a pharmacist accept this responsibility to provide pharmaceutical care He/She must pass through the following criteria • 1) Must posses knowledge and skills in pharmaceutical care such as clinical pharmacology… 18
  • 19. • 2) Must be able to develop relationships with the patients and other health acre professionals needed to provide pharmaceutical care. • 3) Must be available in society/community for patients in time • 4) Should have commitment to quality improvement and assessment procedure. • 5) Must be able to handle the prescription and medication In addition to the above qualities of a pharmacist, the following institutional setup has to be in place: a) System of data collection, Documentation, and Transfer of information b) Reference, resources and equipment. c) Efficient workflow processes Once the above parameters are in proper place, the pharmacist Who is the central figure for pharmaceutical care. And then a pharmacist has the following function to perform 19
  • 20. Functions 1. Collection of patient data 2. Identification of problems 3. Establishing outcome goals through a good therapeutic plan 4. Evaluating treatment alternatives, by monitoring and modifying therapeutic plan 5. Individualizing drug regimens 6. Monitoring outcomes. 20
  • 21. Functions / Practice Principles 1. Data Collection 2. Information Evaluation 3. Formulating a Plan 4. Implementing the Plan 5. Monitoring and Modifying the Plan/Assuring Positive Outcomes 21
  • 22. Practice Principles 1. Data Collection • 1.1 The pharmacist conducts an initial interview with the patient for the purposes of establishing a professional working relationship and initiating the patient's pharmacy record. • In some situations (e.g. pediatrics, geriatrics, critical care, language barriers) the opportunity to develop a professional relationship with and collect information directly from the patient may not exist. • Under these circumstances, the pharmacist should work directly with the patient's parent, guardian, and/or principal caregiver. 22
  • 23. • 1.2 The interview is organized, professional, and meets the patient's need for confidentiality and privacy. • Adequate time is devoted to assure that questions and answers can be fully developed without either party feeling uncomfortable or hurried. • The interview is used to systematically collect patient-specific subjective information and to initiate a pharmacy record which includes information and data regarding the patient's general health and activity status, past medical history, medication history, social history (including economic situation), family history, and history of present illness. • The record should also include information regarding the patient's thoughts or feelings and perceptions of his/her condition or disease. 23
  • 24. • 1.3 The pharmacist uses health/physical assessment techniques (blood-pressure monitoring, etc.) appropriately and as necessary to acquire necessary patient-specific objective information. • 1.4 The pharmacist uses appropriate secondary sources to supplement the information obtained through the initial patient interview and health/physical assessment. • Sources may include, but are not limited to, the patient's medical record or medical reports, the patient's family, and the patient's other healthcare providers. • 1.5 The pharmacist creates a pharmacy record for the patient and accurately records the information collected. The pharmacist assures that the patient's record is appropriately organized, kept current, and accurately reflects all pharmacist-patient encounters. • The confidentiality of the information in the record is carefully guarded and appropriate systems are in place to assure security. 24
  • 25. Practice Principles 2. Information Evaluation • 2.1 The pharmacist evaluates the subjective and objective information collected from the patient and other sources then forms conclusions regarding: (1) opportunities to improve and/or assure the safety, effectiveness, and/or economy of current or planned drug therapy; (2) opportunities to minimize current or potential future drug or health-related problems; and (3) the timing of any necessary future pharmacist consultation. • 2.2 The pharmacist records the conclusions of the evaluation in the medical and/or pharmacy record. • 2.3 The pharmacist discusses the conclusions with the patient, as necessary and appropriate, and assures an appropriate understanding of the nature of the condition or illness and what might be expected with respect to its management. 25
  • 26. Practice Principles 3. Formulating a Plan • 3.1 The pharmacist, in concert with other healthcare providers, identifies, evaluates and then chooses the most appropriate action(s) to: (1) improve and/or assure the safety, effectiveness, and/or cost-effectiveness of current or planned drug therapy; and/or, (2) minimize current or potential future health-related problems. • 3.2 The pharmacist formulates plans to effect the desired outcome. • The plans may include, but are not limited to, work with the patient as well as with other health providers to develop a patient-specific drug therapy protocol or to modify prescribed drug therapy, develop and/or implement drug therapy monitoring mechanisms, recommend nutritional or dietary modifications, add non-prescription medications or non-drug treatments, refer the patient to an appropriate source of care, or institute an existing drug therapy protocol. 26
  • 27. • 3.3 For each problem identified, the pharmacist actively considers the patient's needs and determines the desirable and mutually agreed upon outcome and incorporates these into the plan. • The plan may include specific disease state and drug therapy endpoints and monitoring endpoints. • 3.4 The pharmacist reviews the plan and desirable outcomes with the patient and with the patient's other healthcare provider(s) as appropriate. • 3.5 The pharmacist documents the plan and desirable outcomes in the patient's medical and/or pharmacy record. 27
  • 28. Practice Principles 4. Implementing the Plan • 4.1 The pharmacist and the patient take the steps necessary to implement the plan. • These steps may include, but are not limited to, – contacting other health providers to clarify or modify prescriptions, – initiating drug therapy, – educating the patient and/or caregiver(s), – coordinating the acquisition of medications and/or related supplies, which might include helping the patient overcome financial barriers or lifestyle barriers that might otherwise interfere with the therapy plan, or – coordinating appointments with other healthcare providers to whom the patient is being referred. 28
  • 29. • 4.2 The pharmacist works with the patient to maximize patient understanding and involvement in the therapy plan, assures that arrangements for drug therapy monitoring (e.g. laboratory evaluation, blood pressure monitoring, home blood glucose testing, etc.) are made and understood by the patient, and that the patient receives and knows how to properly use all necessary medications and related equipment. • Explanations are tailored to the patient's level of comprehension and teaching and adherence aids are employed as indicated. • 4.3 The pharmacist assures that appropriate mechanisms are in place to ensure that the proper medications, equipment, and supplies are received by the patient in a timely fashion. 29
  • 30. • 4.4 The pharmacist documents in the medical and/or pharmacy record the steps taken to implement the plan including the appropriate baseline monitoring parameters, and any barriers which will need to be overcome. • 4.5 The pharmacist communicates the elements of the plan to the patient and/or the patient's other healthcare provider(s). The pharmacist shares information with other healthcare providers as the setting for care changes, in order to help maintain continuity of care as the patient moves between the ambulatory, inpatient or long-term care environment. 30
  • 31. Practice Principles 5. Monitoring and Modifying the Plan/Assuring Positive Outcomes • 5.1 The pharmacist regularly reviews subjective and objective monitoring parameters in order to determine if satisfactory progress is being made toward achieving desired outcomes as outlined in the drug therapy plan. • 5.2 The pharmacist and patient determine if the original plan should continue to be followed or if modifications are needed. If changes are necessary, the pharmacist works with the patient/caregiver and his/her other healthcare providers to modify and implement the revised plan as described in "Formulating the Plan" and "Implementing the Plans" above. • 5.3 The pharmacist reviews ongoing progress in achieving desired outcomes with the patient and provides a report to the patient's other healthcare providers as appropriate. As progress towards outcomes is achieved, the pharmacist should provide positive reinforcement. 31
  • 32. • 5.4 A mechanism is established for follow-up with patients. • The pharmacist uses appropriate professional judgment in determining the need to notify the patient's other healthcare providers of the patient's level of adherence with the plan. • 5.5 The pharmacist updates the patient's medical and/or pharmacy record with information concerning patient progress, noting the subjective and objective information which has been considered, his/her assessment of the patient's current progress, the patient's assessment of his/her current progress, and any modifications that are being made to the plan. Communications with other healthcare providers should also be noted. 32